Hofseth BioCare ASA
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HOFBF research report →
Companywww.hofsethbiocare.no
Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force.
- CEO
- Jon Olav Odegard
- IPO
- 2018
- Employees
- 72
- HQ
- Ålesund, NO
Price Chart
Valuation
- Market Cap
- $65.82M
- P/E
- -3.81
- P/S
- 1.96
- P/B
- -6.87
- EV/EBITDA
- -10.68
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 18.79%
- Op Margin
- -44.13%
- Net Margin
- -52.83%
- ROE
- 728.56%
- ROIC
- -50.03%
Growth & Income
- Revenue
- $254.29M · -1.22%
- Net Income
- $-134,804,867 · -9.24%
- EPS
- $-0.33 · -10.00%
- Op Income
- $-112,623,396
- FCF YoY
- -358.70%
Performance & Tape
- 52W High
- $0.18
- 52W Low
- $0.15
- 50D MA
- $0.17
- 200D MA
- $0.17
- Beta
- 0.25
- Avg Volume
- 35.64K
Get TickerSpark's AI analysis on HOFBF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HOFBF Coverage
We haven't published any research on HOFBF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HOFBF Report →